Litcius/Paper detail

Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort

Abdul Rafeh Naqash, Biagio Ricciuti, Dwight H. Owen, Vaia Florou, Yukihiro Toi, Cynthia R. Cherry, Maida Hafiz, Andrea De Giglio, Mahvish Muzaffar, Sandip H. Patel, Shunichi Sugawara, Jarred Burkart, Wungki Park, Rita Chiari, Jun Sugisaka, Gregory A. Otterson, Gilberto Lopes, Paul R. Walker

2020Cancer Immunology Immunotherapy97 citationsDOIOpen Access PDF

Topics & Concepts

NivolumabMedicineDiscontinuationAdverse effectInternal medicineLung cancerMultivariate analysisOncologyCohortCancerGastroenterologyImmunotherapyCancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease PrognosisCancer Diagnosis and Treatment
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort | Litcius